Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on ...

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 2.5% in the afternoon session after the company announced it would present new data from eight studies at the 2025 San Antonio ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

A committee has recommended an expansion of the indication for Winrevair, an approved injection therapy for adults with PAH, ...

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...

Pivot Bio, one of the world's leading innovative agtech companies, today announced six seasoned professionals have joined its senior management team. They ...

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026. FORT ...

SUMO E1 inhibition inhibits ocular lens fibrosis by suppressing TGFβ2-induced SMAD4 SUMOylation Fibrotic cataracts are a ...

Neoliensinine improves T-cell malignancy therapy by inducing TUBA1B-mediated lysosomal degradation of STING T-cell ...

Pediatrician Kristin Sohl has lost count of how many times parents of children with autism have asked her for a prescription for leucovorin — the drug thrust into the spotlight after President Donald ...

Myelodysplastic syndrome (MDS) arises from defective blood stem cells that progressively lose their normal functions.